Top member reports
Company Report
Last edited 7 months ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#3
Performance (91m)
17.9% pa
Followed by
1398
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#The fall and fall of PTM
stale
Last edited 7 months ago

06-May-2025: Platinum-PTM-Funds-Under-Management---30-April-2025.PDF

See also: Platinum-(PTM)-Funds-Under-Management---April-2024.PDF (12 months ago)

And: Platinum-(PTM)-Funds-Under-Management---May-2023.PDF (23 months ago - that's as far back as Commsec would let me go).

History of declining FUM and large outflows:

  • April 2023: FUM: $18.44 Billion, with net outflows of $324 million in May 2023.
  • April 2024: FUM: $13.75 Billion, with net outflows of approximately $1.65 billion that month.
  • April 2025: FUM: $9.65 Billion, with net outflows of approximately $243 million that month.

So their Funds Under Management have almost halved in two years; it's like a slow motion version of what happened over at MFG, so not as volatile, but still nasty.

a56fd7d53bda310c1c61e1dc03fbc9481921dc.png

Here's their 5 year chart:

cc55c86eb865e47f787d0371542ca36049fdad.png

PTM is a fund manager, and they do well if the globally-focused funds that they manage also do well, because they can charge performance fees on any outperformance (vs their benchmark, usually the MSCI ex-Australia index) in addition to their ongoing base management fees.

PTM's funds have struggled, in part because while Hamish Douglass over at MFG (back in the day, when he was still at MFG and seen as - and was - the driving force behind MFG) backed big US tech, Kerr Neilson (who had the financial backing of George Soros back then) - the founder of Platinum Asset Management - put most of Platinum's chips on Asia, and more specifically China, and that hasn't worked out so well for Kerr or his successor at Platinum Asset Management, Andrew Clifford, in recent years, so underperformance means less performance fees means less profits for the manager (PTM) which is made worse by declining FUM where even the base management fees have been declining as the funds they manage have almost halved over the past two years.

This is of course driven by continuing redemptions (people pulling money out of Platinum funds), a trend which is only likely to continue as the value of ETFs becomes more and more obvious.


Disc: Not held, although I held both MFG and PTM, as well as some of their funds in prior years - not for a few years now however.

#The fall and fall of PTM
stale
Last edited 12 months ago

Platinum Asset Management (PTM -14.4%) reports it is no longer in discussions with Regal. Now below its pre-bid price. 

09-Dec-2024: PTM - End-of-Regal-discussions,-special-dividend--turnaround.PDF

e27a9055553ecb8bf80fa18807f6edd67115c4.png

Not the Chrissy Present PTM shareholders were hoping for. Shows that buying into companies based on M&A arbitrage doesn't always work out. PTM were bought up based on the 17th September announcement of the Non-binding-indicative-proposal-from-Regal-Partners-Limited-for-PTM.PDF but today with the disclosure that Regal have walked away from the deal after a shortened period of DD, PTM, the manager of the Platinum managed funds, has dropped -14.35% and is now trading below the level it was pre-bid.

It's not been a positive experience for PTM shareholders this past year:

1ed5df3d539657929cf2cce031359eee7a30b1.png

But it's been worse for anybody who's been holding PTM or MFG since mid-2021.

f5627090a56dd93e9a0f78216a16c152e02264.png

While the All Ords Accumulation Index (XAO) has put on +27% in 5 years, both Magellan Financial Group (MFG) and Platinum Asset Management (PTM) are both down -80% over the same period. It's just taken PTM twice as long to get there. MFG were already down -80% in July 2022, then they went even lower and have now come back up to ONLY being down -80% over 5 years once again.

Both of these Australian fund managers who specialise in overseas sharemarket investments have ended up falling by the same amount but 5 years ago they had very different perspectives on where the best returns could be made. At that time Hamish Douglass (MFG's co-founder and CIO - Chief Investment Officer - at that time) was still flying high at Magellan and insisting that there were far better risk-adjusted returns to be made in US tech stocks and fast food franchises than there were in Asia, particularly China, where he said there were elevated risks, whereas PTM's founder, Kerr Neilson had stepped down as CEO of PTM in 2018 and was replaced by Andrew Clifford, the CIO of Platinum who adopted both roles, and Clifford strongly believed that the majority of the companies that Magellan were investing in were far too expensive, and there was far more value to be found in Asia, particularly in China.

On the surface it seemed like MFG were growth investors and PTM were value investors, but the reality is never quite that simple.

Kerr Neilson appeared to share Clifford's views, however Kerr later resigned from the Board of Platinum Asset Management in 2022.

What changed between the end of 2019 and mid-2021 was firstly that Hamish decided to break his "no China investments" rule and make some large investments in Tencent and Alibaba, and then the Chinese central government cracked down on those companies and others where they felt the billionaire founders and managers were getting too bold and acting like they lived in and were operating in a democracy where their own views were valuable and could be freely shared, even when those views were critical of some Chinese Central Government policies. Those Chinese tech billionaires were reminded that was certainly not the case. Spin-outs and IPOs were blocked. Billionaires like Jack Ma went missing for months. And Chinese tech stocks got smashed, and the entire Chinese sharemarket went into a deep slump as a result.

In Magellan's case, there were also other factors, like Hamish making some big bets on what turned out to be losing positions in the US at the same time, but the Chinese tech stock "correction" affected both Magellan and Platinum.

Platinum continued to underperform their global peers, and Magellan went from being consistent outperformers to becoming underperformers.

With Magellan, it was a more bumpy ride over 10 years, with highs and lows, whereas Investors in Platinum over the past decade have had a less eventful and more calm ride down to lower and lower share prices.

0617e7f968ad5bcf72d238b11d9b47c1d497ba.png

And now Regal have had a look under their bonnet and didn't much like what they saw, so have walked.

I have been invested in both PTM and MFG at various times, and have made money and lost money on both. The losses have outweighed the gains however, so with the benefit of hindsight I should have stayed well away from both.

They used to scan well because they had really high ROE, because as fund managers they have relatively fixed costs, and when their FUM was increasing the extra Funds Under Management just increased the bottom line profits without increasing costs. However the bottom line with both of them depended on them outperforming so they could charge performance fees on top of their base management fees, and their profitability declined as their FUM declined. It's a competitive sector, and people want to back winners in terms of which of the underlying funds they invest in, so companies that don't consistently outperform are always going to struggle as they lose FUM.

It's not a sector I invest in these days. Lessons learned.

#International Health Care Fund
stale
Last edited 5 years ago

09-Nov-2020:  https://www.livewiremarkets.com/wires/platinum-there-s-a-revolution-in-biotech-and-you-need-to-be-part-of-it-2020-11-09

Part of Livewiremarkets.com's FUNDS OF THE FUTURE series

9TH NOV, 20:  Platinum: There's a revolution in biotech and you need to be part of it

By JAMES MARLAY, Livewire Markets

Investing in biotech is often seen as binary: you either win big or lose everything. The success of CSL has been well chronicled, however, is it possible to consistently pick long-term winners within an industry rampant with regulation and experimental uncertainty?

Having cut her teeth as a research scientist, Dr Bianca Ogden of Platinum Asset Management is not your average fundie. Dr Ogden fell into funds management after being intrigued by a simple question: How on earth can senior executives make decisions of what drug to develop when they are not in the lab? This grew into a passion for understanding the keys to success within the healthcare industry, and after 17 years of working for Platinum, she has not looked back.

"In the 17 years I've worked in funds management, I have never experienced the speed and excitement of new technologies that we are seeing today."

In this edition of Funds of the Future, Dr Ogden sat down with me to discuss emerging trends in the biotech sector and how the Platinum International Health Care Fund  is looking to play these.

--- click on the link at the top to read the whole article ---

[I do NOT currently hold PTM shares, which is Platinum Asset Management, the manager of the various Platinum funds.  At this point, two of those funds are listed on the ASX, being Platinum Capital (PMC) and Platinum Asia Investments (PAI).  They also have a number of unlisted funds, including the one discussed in this article - the Platinum International Health Care Fund.  Platinum WERE the leading global investment managers based here in Australia, but have been overtaken in recent years by Hamish Douglass' Magellan Financial Group (MFG), and the outstanding performance of the various Magellan funds.  Kerr Neilson's Platinum tend to focus predominantly on Asia, while Magellan's have traditionally invested more in the leading U.S. tech stocks (except for Amazon, which Hamish likes a lot but can't justify buying based on the market valuation).  Interestingly, both Platinum and Magellan are serious investors in both Alibaba and Tencent, the two largest Chinese-based tech giants, who both do business globally and are both very exciting companies.  I have made money owning PTM shares in prior years.  Lately, I have been holding PAI shares, but in the past week have sold them and rotated that money into EAI - Ellerston Asian Investments - because I think EAI is a better opportunity at this point, and I really like Mary Manning's communication and investment style.  However, for a dedicated global health care fund, this Platinum fund sounds interesting to me.  Pity it isn't ASX-listed.]

#Platinum vs Magellan
stale
Last edited 6 years ago

"We always overestimate the change that will occur in the next two years and underestimate the change that will occur in the next ten." - Bill Gates

Magellan vs Platinum,   or   Hamish Douglas vs Andrew Clifford: 

17-Sep-19 - The two CIOs of our two most prominent ASX-listed global funds management businesses (MFG & PTM) have been doing a few odd joint interviews over the past year or two, and this one is a good one.  In this "Livewire Live 2019" piece, Patrick Poke from Livewire Markets reviews the latest joint interview between those two CIOs whose views are often very, very different (but who both own Ali Baba, the "Amazon of China"; in fact, Magellan are a top-10 shareholder of Ali Baba).

https://www.livewiremarkets.com/wires/magellan-and-platinum-10-years-from-now-this-is-how-the-investing-world-has-changed

If you want to skip to the video - click here:  https://youtu.be/7Mp2gctWb6k

I always think that Hamish Douglass comes off looking and sounding far better than Andrew Clifford does whenever they go head to head, but good on Andrew for having a go once more.  It is interesting how they have similar ideas or viewpoints on some things, such as the opportunity that exists in the rise of the Chinese consumer (& associated consumer expenditure in China) but how they tend to approach participation in that theme in completely different ways (- for the most part, except for Ali Baba clearly, which they both hold).  Anyway, I strongly recommend watching this video. 

Magellan has two key consultants on the topic of interest rates; Kevin Warsh, a former Federal Reserve member who may serve as the next President of the Fed, and none other than Janet Yellen herself, the previous President of the Fed.  Hamish says their advice played a role in him adjusting his views on rates. He now sees three percent as a base case for long term rates, but says that scenarios between zero and two percent shouldn't be ruled out.  These sort of insights have implications for the Australian market as well of course. 

Andrew's view is that negative interest rates are unsustainable and could destroy the banking sector in some countries, so he believes that central banks have done about as much as they can and we're going to get fiscal stimulus in a range of countries and regions and that could lead to increased demand for materials and that in turn could lead to inflation which would support higher rates.

Hamish says that, above all, locking yourself into one view and one position is dangerous and you have to be ready to adapt quickly, because while it's good to have a view (and they have a view) on what is most likely to happen, you have to keep in mind that a range of other eventualities is entirely possible.  He also said that while he has the best advisers, his team doesn't always agree with them either.  So, have a view based on good, sound reasoning, and position accordingly, but don't be locked in to that position - be ready to adapt - and fast, because things can and do change, and sometimes very rapidly.  Very good reading/viewing!

#Bear Case
stale
Added 6 years ago

07-Mar-2020:  In this very recent "Buy Hold Sell" segment from Livewire Markets, Ben Clark from TMS Capital makes a pretty solid BEAR case for PTM, starting at around the 3:42 mark (3 mins, 42 seconds):  https://www.livewiremarkets.com/wires/buy-hold-sell-5-contrarian-stock-ideas